Evidence map›Paper›PMID 23974971›Full record

ArticleEpigenetics2013

Real-time dynamics of methyl-CpG-binding domain protein 3 and its role in DNA demethylation by fluorescence correlation spectroscopy.

Yi Cui, Il-Hoon Cho, Basudev Chowdhury, Joseph Irudayaraj

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Visualizing Epigenetics: A Review of Microscopy Techniques for Investigating DNA Methylation Patterns, Chromatin Structure, and Gene Expression.Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada · 2025
    Review
  2. Article
  3. Mechanomemory in protein diffusivity of chromatin and nucleoplasm after force cessation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inside single cells: quantitative analysis with advanced optics and nanomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Yi CuiBiological Engineering and Bindley Bioscience Center, Purdue University; West Lafayette, IN USA.
Il-Hoon ChoBiological Engineering and Bindley Bioscience Center, Purdue University; West Lafayette, IN USA.
Basudev ChowdhuryBiological Engineering and Bindley Bioscience Center, Purdue University; West Lafayette, IN USA.
Joseph IrudayarajBiological Engineering and Bindley Bioscience Center, Purdue University; West Lafayette, IN USA.
Purdue University West Lafayette · US

Funding

Indiana Clinical and Translational Science Institute (UL1)UL1TR000006 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI SHEKHAR, ANANTHA · 2012 to 2013
$5.6M
Interdisciplinary Cancer Prevention Research Internship ProgramR25CA128770 · NCI · PURDUE UNIVERSITY · PI TEEGARDEN, DOROTHY · 2008 to 2012
$1.5M
NCATS NIH HHS UL1 TR000006NCI NIH HHS R25 CA128770NCI NIH HHS R25CA128770
6 · The paper itself

Abstract

With unprecedented development in technology, epigenetics is recognized as a substantial and flexible regulatory pathway for phenotyping. Cytosine methylation and its subsequent oxidization have attracted significant attention due to their direct impact on gene regulation, in association with methyl-CpG-binding domain proteins (MBDs) and transcription related factors. In this study we record the dynamics of DNA demethylation using the recombinant MBD3-GFP protein in living cells under hypoxia and Decitabine treatment using Fluorescence Correlation Spectroscopy (FCS) by monitoring the diffusion dynamics of MBD3. Our study shows a DNA-replication-independent decrease of 5-methylcytosine (5mC)/5-hydroxymethylcytosine (5hmC) under hypoxia vs. a dependent decrease under Decitabine treatment. Further, we define a significantly faster diffusion of MBD3 in the nucleus as a precursory event for active demethylation rather than the Decitabine induced passive demethylation. By monitoring the diffusion of bound and unbound MBD3 in the nucleus we were able to identify and characterize hypoxia-sensitive cells from insensitive/tolerant cells, as well as the respective contribution to active demethylation in a time-dependent manner. Last, we quantitatively describe the concurrent decreasing trend in all of the three oxidized products of 5mC, which points to the potential involvement of ten-eleven-translocation proteins (TETs) in hypoxia induced active demethylation. Overall, for the first time we correlate the dynamic process of DNA demethylation with the biophysical properties of the corresponding DNA binding proteins in live single cells by single molecule spectroscopy.

Indexed as

5-MethylcytosineAzacitidineCell HypoxiaCytosineDecitabineDNADNA-Binding ProteinsDNA Modification MethylasesHeLa CellsHumansSingle-Cell AnalysisSpectrometry, Fluorescence5-hydroxymethylcytosine5-MethylcytosineAzacitidineCytosineDecitabineDNADNA-Binding ProteinsDNA Modification MethylasesMBD3 protein, humanbiophysicsDNA demethylationdynamicsfluorescence correlation spectroscopy (FCS)methyl-CpG-binding domain protein 3 (MBD3)nuclear proteinten-eleven-translocation proteins (TETs)

Identifiers

PMID23974971
PMCPMC3891690
OpenAlexW2092504072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.